The QualityStocks Daily Friday, December 7th, 2018

Today's Top 3 StockMarketWatch

CryptoCurrencyWire (HIPH) +59.55%

BUYINS.NET (DOMO) +30.52%

StreetInsider (OZM) +29.17%

The QualityStocks Daily Stock List

Medicine Man Technologies, Inc. (MDCL)

Stockwatch, Simply Wall St, Daily Marijuana Observer, The Street, Insider Financial, Stockopedia, Marketbeat, Stockhouse, Insider Tracking, CFN Media Group, and MarketWatch reported previously on Medicine Man Technologies, Inc. (MDCL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Medicine Man Technologies, Inc. represents and licenses the cultivation and dispensary Intellectual Property (IP) of Medicine Man - a well-respected Tier III operator in the State of Colorado. Medicine Man cultivates and sells through its parent company Medicine Man Denver, the largest cultivation/retail facility in Colorado.

Medicine Man Technologies provides cultivation consulting services for cannabis growing technologies and methodologies. The Company is one of the nation’s foremost cannabis brand development and consulting businesses. Medicine Man Technologies is based in Denver, Colorado. The Company lists on the OTCQX.

Medicine Man is focusing on working with clients to use its experience, technology, and training to help secure licenses in states with newly emerging regulations. The Company is also focusing on cultivation practices through its deployment of Cultivation MAX and eliminating the liability of single grower dependence.

Medicine Man works closely with industry-leading extraction partners. These partners provide the required licensing service support and formulations to help customers with their planned deployment of a successful processing facility. Medicine Man’s risk-averse cannabis cultivation technology delivers consistent, high quality, high yield production within a clean-room style environment. The Company’s state-of-the art dispensary model ensures patients and consumers have safe and secure access to an assortment of medical and/or recreational cannabis products.

Medicine Man Technologies is also continuing the expansion of its Brands Warehouse concept. Furthermore, the Company engages in retail operations of cannabis products. It also provides general business and referral management for other related service providers for its customers.

Medicine Man Technologies and Solis Tek, Inc. have a cooperative agreement. Solis Tek becomes Medicine Man’s recommended supplier of High Intensity Discharge (HID) lighting technologies for its current and prospective consulting and sales relationships. Medicine Man has completed and totally integrated three acquisitions, which are Pono Publications, Success Nutrients, and the Denver Consulting Group.

Medicine Man Technologies has also acquired the Big Tomato retail supplier business. The Big Tomato retail business carries a wide array of grow related products. It will also be acting as another distribution hub for Medicine Man’s Success Nutrients product line.

Recently, Medicine Man Technologies provided financial results for the quarter ended September 30, 2018. During the three months ending September 30, 2018, Medicine Man generated Operating Revenues of $4,647,163. This represents an increase of roughly 400 percent versus Revenues of $928,264 in the three months ending September 30, 2017.

Other Income for the three months ending September 30, 2018 rose to $2,605,672 versus losses in the three months ending September 30, 2017 of ($165,881). Medicine Man reported Net Income related to the three months ending September 30, 2018 of $4,950,679 or $0.18 per share versus losses of ($485,627) as related to the three months ending September 30, 2017.

Medicine Man Technologies, Inc. (MDCL), closed Friday's trading session at $1.34, down 2.90%, on 43,977 volume with 53 trades. The average volume for the last 3 months is 72,844 and the stock's 52-week low/high is $1.10/$3.40.

chart

Cannabics Pharmaceuticals, Inc. (CNBX)

TopPennyStockMovers, Promotion Stock Secrets, TheMicrocapNews Cannabis Financial Network News, Wealth Insider Alert, Wall Street Mover, SmallCapVoice, StreetAuthority Daily, Wall Street Daily, Stockgoodies, and Market Intelligence Center reported earlier on Cannabics Pharmaceuticals, Inc. (CNBX), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Cannabics Pharmaceuticals, Inc.’s commitment is to the development of advanced cannabinoid-based treatments and therapies. The Company’s primary focus is the development of novel therapies and biotechnological tools designed to provide relief from diverse ailments and treat human malignancies. Cannabics’ vision is to create individually tailored natural therapies for cancer patients, utilizing advanced screening systems and personalized bioinformatics tools. OTCQB-listed, Cannabics Pharmaceuticals is headquartered in Bethesda, Maryland.

Cannabics has licensed Research and Development (R&D) based in Israel. This R&D’s dedication is to the development of palliative and personalized anti-cancer treatments channelling the multipurpose therapeutic values of cannabinoids to create tailored therapies for cancer patients. The Company’s integrated technology has created a successful medically standardized delivery system providing patients natural, reliable, and safe therapy. Cannabics has created a Genetic lab. This lab will develop diagnostic tools based on human genome, tumor genetics, and cannabinoids.

The Company’s advanced tools include novel delivery systems, personalized medicine diagnostics, as well as therapies based on cannabinoid compounds. Cannabics’ main technology is Cannabics SR. This technology is for a long acting oil capsule that provides a safe, effective, and reliable administration of cannabis. The technology’s composition is exclusively from food grade materials.

Cannabics Pharmaceuticals announced in August 2018 a partnership agreement with Eroll Grow Tech ltd (Seedo), developer of the world's first fully-automated grow device designed specifically for cannabis. Through this new partnership, Cannabics Pharmaceuticals and Seedo will develop the first controlled device for growing medical cannabis at home, ensuring sustainable quality and supply of natural, pesticide free product.

Recently, Cannabics Pharmaceuticals announced the results of its pilot study to test the efficacy of Cannabics capsules for the treatment of cancer anorexia-cachexia syndrome (CACS) in advanced cancer patients. Preliminary findings showed that all patients who were involved in the study for the first four and a half months reported an increase in appetite, and also 83 percent of all those that completed the study.

Moreover, results demonstrated a weight increase of greater than 10 percent for 60 percent of the patients who completed the study. The remaining patients had a stable weight. Additionally, 50 percent of the patients who completed the study reported pain reduction and sleep improvement.

Last week, Cannabics Pharmaceuticals announced it filed a provisional patent application with the US Patent Office. The patent covers Cannabics’ novel drug targeting technology accustomed to deliver cannabinoid compounds. Employing a magnetic delivery system, the unique non-invasive approach permits external and internal systemic delivery of cannabinoids to the actual area of tumors within the patient.

Cannabics Pharmaceuticals, Inc. (SVBL), closed Friday's trading session at $0.399, down 1.86%, on 78,988 volume with 58 trades. The average volume for the last 3 months is 434,100 and the stock's 52-week low/high is $0.389/$2.99.

chart

El Capitan Precious Metals, Inc. (ECPN)

HotOTC, StockEgg, StockRich, TopPennyStockMovers, SmallCapVoice, PennyInvest, CoolPennyStocks, AllPennyStocks, PennyTrader Publisher, BullRally, MadPennyStocks, PennyStockVille, and OTCPicks reported on El Capitan Precious Metals, Inc. (ECPN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

El Capitan Precious Metals, Inc. is a mining company based in Scottsdale, Arizona. It mainly engages in the mining of precious metals and other minerals. The Company chiefly holds interest in the El Capitan gold-silver property situated close to Capitan, New Mexico, in Lincoln County. El Capitan Precious Metals’ principal asset is its wholly-owned subsidiary El Capitan, Ltd., an Arizona corporation.

The El Capitan, Ltd. subsidiary holds the 100 percent equity interest in the El Capitan property. The Company’s primary objective is the sale of the El Capitan property.

The El Capitan deposit has been known as a potential iron ore resource for numerous decades. The El Capitan deposit has a near-surface, pervasive nature. All of this takes place above the regional water table. This provides the potential for a low mining cost and a long life operation.

El Capitan Precious Metals owns 3,840 acres of mining property in Lincoln County. This includes 80 acres of patented and 3,760 acres of leased property. These include 188 mining claims. The El Capitan property encompasses 354 Bureau of Land Management (BLM) lode claims and four patented claims.

El Capitan Precious Metals has enhanced its relationship with Logistica US by way of an agreement under which El Capitan will provide to Logistica concentrated ore to their specifications at the mine site. Logistica will transport, process, as well as refine the precious metals concentrates to sell to precious metals buyers. The agreement is in addition to and complements the previously announced agreement for the sale of iron ore for use in construction.

In December 2017, El Capitan Precious Metals announced that it entered into an agreement with a refiner that will buy, refine, and sell the hyper-concentrates generated by the pilot plant. Moreover, the Company reported that the refiner has spent a considerable amount of time with its contract miner at the pilot plant and at the mine site.

This past January, El Capitan Precious Metals announced that an agreement was executed in December 2017 for the sale of the Company’s precious metal hyper-concentrates. El Capitan Chairman and Chief Executive Officer, Mr. John F. Stapleton reported that El Capitan reached a final agreement with a buyer and executed a Purchase Agreement for all remaining hyper-concentrates produced by the Pilot Plant from the concentrate materials stored at the bonded warehouse in Tucson, Arizona.

The sale represents the last El Capitan Pilot Program activity. It successfully completes the objectives of the Pilot program.

This month, El Capitan Precious Metals reported a breach of contract by the buyer of concentrates. The Company reported that it was informed on March 30, 2018, that the contracted buyer to purchase and process the concentrates from El Capitan Precious Metals decided not to process the material. Instead, the contracted buyer is offering to ship the material back to El Capitan Precious Metals.

El Capitan is investigating the matter. The Company said it will take all necessary and proper steps to pursue civil and criminal litigation of the matter, if appropriate upon further investigation, upon the material being returned. El Capitan Precious Metals will provide further details at the 2018 Shareholder Meeting scheduled for Wednesday, May 23, 2018 in Scottsdale, Arizona.

El Capitan Precious Metals, Inc. (ECPN), closed Friday's trading session at $0.013715, up 1.59%, on 525,600 volume with 14 trades. The average volume for the last 3 months is 90,415 and the stock's 52-week low/high is $0.0081/$0.045.

chart

CurAegis Technologies, Inc. (CRGS)

InvestorsHub and OTC Markets reported on CurAegis Technologies, Inc. (CRGS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CurAegis Technologies, Inc. develops and markets advanced technologies in the areas of power, safety, and wellness. The Company consists of two independent divisions - its CURA Division and its Aegis Division.  CurAegis is currently centering on commercialization strategies in different technologies. These include the CURA system, which includes the myCadian™ watch that measures degradation of alertness and sleep attributes; the Z-Coach e-learning education and training tool, and the Aegis hydraulic pump. CurAegis Technologies is based in Rochester, New York.

The CURA System comprises hardware and software that measures many metrics to establish that a person's ability to perform a task or job appears to be degrading. The CURA division is developing a proprietary technology and family of products designed to measure the decrease in a person’s alertness and to train persons on how to improve alertness levels. The CURA™ system and the myCadian™ watch enable the user and third parties to anticipate and prevent undesired or disastrous situations caused by the degradation of alertness.

CurAegis Technologies completed its validation studies of the CURA System at the University of Colorado at Boulder and the University of Rochester Medical Center. The Company earlier said that it can now state that it can predict a person’s fatigue level, at close to laboratory accuracy, in real-time.

The Z-Coach e-learning tool was acquired by CurAegis Technologies in September of 2015. The first of six Z-Coach e-learning modules, Z-Coach Aviation, was designed for aviation professionals.

Additionally, the Company’s Aegis hydraulic pump (Aegis Division) is an innovative hydraulic design. Its goal is to deliver better efficiencies in a package that is smaller and lighter than contemporary technologies.

Regarding the Aegis Division’s Aegis Pump and Motor, it has eliminated the rotating piston group (the cylinders are stationary). This makes the pump very robust and easy to manufacture. The Company’s patented valving has been integrated to increase efficiencies at peak and off peak operation.

Concerning the CURA System, CurAegis Technologies is on schedule to have its system set for shipments in Q3. Moreover, concerning Aegis Pumps and Motor, the new motor is in development and the Company’s prototype is scheduled to be available this month.

CurAegis Technologies, Inc. (CRGS), closed Friday's trading session at $0.21, up 5.00%, on 31,638 volume with 9 trades. The average volume for the last 3 months is 25,633 and the stock's 52-week low/high is $0.10/$0.49.

chart

Helius Medical Technologies, Inc. (HSDT)

OTC Markets, Stockhouse, MarketWatch, and InvestorsHub reported on Helius Medical Technologies, Inc. (HSDT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Helius Medical Technologies, Inc. is a medical technology company based in Newtown, Pennsylvania. Its focus is neurological wellness and it works to develop, license, and also acquire innovative non-invasive treatments designed to amplify the brain’s ability to heal itself. NeuroHabilitation is a division of Helius Medical Technologies. NeuroHabilitation is developing a unique technology as a potential treatment for neurological symptoms caused by disease or trauma. Helius Medical Technologies’ shares trade on the OTC Markets Group’s OTCQB.

The Company’s intention is to file for U.S. Food and Drug Administration (FDA) clearance for the Portable Neuromodulation Stimulator (PoNS™). The PoNS™ device is an investigational non-invasive device designed to deliver neurostimulation by way of the tongue.

PoNS™ Therapy combines the use of the device with physical therapy. Currently, it is undergoing evaluation in a multicenter clinical trial for the treatment of balance disorder in patients with mild-to-moderate Traumatic Brain Injury (mTBI).

In 2013, The NeuroHabilitation division signed a Collaborative Research and Development Agreement (CRADA) with the US Department of Defense. This is to develop and manage clinical and regulatory activities for the PoNS™ device and CN-NINM technologies.

NeuroHabilitation successfully executed a sole source cost sharing contract with the U.S. Army Medical Research and Materiel Command (USAMRMC). The contract supports Helius’ registrational trial investigating the safety and effectiveness of the PoNS™. The PoNS™ is undergoing study in Canada for chronic balance and gait symptoms caused by Multiple Sclerosis.

Helius Medical Technologies announced in January 2017 that MedStar National Rehabilitation Hospital in Washington D.C. was launched as the sixth site to provide services supporting the Company’s ongoing pivotal trial investigating PoNS™ Therapy for the treatment of subjects with balance disorder resulting from mild-to-moderate Traumatic Brain Injury (TBI).

Clinical trial sites in the U.S. and Canada include Oregon Health and Science University in Portland, Oregon; Montreal Neurofeedback Center in Montreal, Quebec; Orlando Regional Medical Center in Orlando, Florida; HealthTech Connex, Inc. in Surrey, British Columbia; and Virginia Commonwealth University in Richmond, Virginia.

Recently, Helius Medical Technologies and the United States Army Medical Research and Materiel Command (USAMRMC) announced that the last subject was enrolled in the registrational clinical trial to investigate the safety and effectiveness of the PoNS™ device for the rehabilitation of chronic balance deficits caused by mild-to-moderate Traumatic Brain Injury (mTBI). The intention of the trial is to serve as the foundation for Helius to submit applications for marketing clearance in the U.S., Canada, and Europe for the PoNS™ device.

Last week, Helius Medical Technologies announced that via its wholly-owned subsidiary NeuroHabilitation Corporation (NHC), it has executed an extension to its Cooperative Research and Development Agreement (CRADA) with the US Army Medical Research and Materiel Command (USAMRMC) through 2018 and extended the deadline for commercialization of the PoNSTM Therapy to December 31, 2021.

Helius Medical Technologies, Inc. (HSDT), closed Friday's trading session at $9.16, up 3.27%, on 115,941 volume with 1,384 trades. The average volume for the last 3 months is 67,938 and the stock's 52-week low/high is $7.15/$13.19.

chart

Nautilus Minerals, Inc. (NUSMF)

OTC Markets, Equities, Marketwired, InvestorsHub, Barchart, Junior Mining Network, The Street, PennyStockTweets, Stockhouse, MarketWatch, and YCharts reported earlier on Nautilus Minerals, Inc. (NUSMF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Nautilus Minerals, Inc. is the first company to explore the ocean floor for polymetallic seafloor massive sulphide deposits. Nautilus is developing a production system using existing technologies adapted from the offshore oil and gas industry, dredging and mining industries to enable the extraction of these high-grade Seafloor Massive Sulphide (SMS) systems on a commercial scale.

Nautilus Minerals is headquartered in Toronto, Ontario. The Company has its Operations office in Brisbane, Australia. Nautilus also has offices in Kavieng, New Ireland, Papua New Guinea, and Nuku'alofa, Tonga, South Pacific. A seafloor resource exploration company, Nautilus Minerals lists on the OTC Markets.

The Company explores and develops the ocean floor for copper, gold, silver, and zinc SMS deposits. In addition, it explores for manganese, nickel, copper, and cobalt nodule deposits. Nautilus has its copper-gold project called Solwara 1. It is under development in the territorial waters of Papua New Guinea (PNG).

The Solwara 1 deposit sits on the seafloor at a water depth of roughly 1600 meters. Solwara 1 contains a copper grade of about 7 percent. This compares with land-based copper mines, where the copper grade today averages 0.6 percent. Gold grades of considerably more than 20 g/tonne have been recorded in some intercepts at Solwara 1. The average grade is approximately 6 g/tonne. Nautilus Minerals also holds highly prospective exploration acreage in the western Pacific (granted and under application), and in international waters in the Central Pacific.

Nautilus Minerals is now negotiating the terms of an agreement with arm's length third parties. This would involve the establishment of a new joint venture company (the Vessel JV) to be owned by the third parties and Nautilus’ subsidiary, Nautilus Minerals Niugini Limited (NMN).

The purpose of the Vessel JV would be to fund the acquisition of the Production Support Vessel (PSV) that Nautilus had earlier arranged to be obtained via MAC Goliath Pte Ltd (MAC) and the integration expenses of installing the mining equipment on the PSV. The Vessel JV would own and operate the fully integrated PSV. It would charter the PSV to the existing Solwara 1 JV between NMN and the Independent State of Papua New Guinea’s nominee, Eda Kopa (Solwara) Limited.

Nautilus Minerals, Inc. (NUSMF), closed Friday's trading session at $0.0569, up 5.76%, on 476,749 volume with 17 trades. The average volume for the last 3 months is 169,466 and the stock's 52-week low/high is $0.0353/$0.31.

chart

hopTo, Inc. (HPTO)

Tiny Gems, Money Morning, Marketbeat.com, Wall Street Mover, SmallCapVoice, TopPennyStockMovers, and PennyStocks24 reported earlier on hopTo, Inc. (HPTO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

hopTo, Inc. is a developer of application publishing software and a mobile productivity workspace platform. The hopTo mobile solution delivers a first-rate user experience without compromising enterprise security. It delivers a mobile experience that changes the way one works and lives without any compromises or boundaries. The Company is a Citrix Ready® Premier Partner. hopTo is headquartered in Concord, New Hampshire.

The hopTo mobile solution enables one to completely embrace a mobile lifestyle. hopTo brings a new standard of mobile productivity with custom, touch enabled access to existing Windows applications and documents. hopTo are developers of application software. This includes application virtualization software and cloud computing software for multiple computer operating systems. This includes Windows, UNIX, and a number of Linux-based variants.

hopTo Work enables customers to rapidly transform their legacy applications to become touch friendly on modern mobile devices. Moreover, hopTo worked during 2015 and 2016 to integrate hopTo Work with certain software products offered by Citrix Systems.

The Company’s application publishing software solutions sell under the brand name GO-Global. GO-Global is an application access solution for use and/or resale by independent software vendors (ISVs), corporate enterprises, governmental and educational institutions, and others who desire to leverage cross-platform remote access and Web-enabled access to their existing software applications, as well as those who are installing secure, private cloud environments.

This past November, hopTo announced its financial results for Q3 ended September 30, 2017. For Q3 2017, Revenue was $1.026 million; Net Profit was $254,000; and Basic and Diluted Earnings per Share was $0.03.

Total Revenue for the first nine months of Fiscal Year 2017 was $2.93 million. This represents an increase of about 2.4 percent from $2.86 million for the same period in 2016. This revenue is entirely from hopTo’s GO-Global products and services.

For the first nine months of 2017, hopTo reported a Net Profit of $87,000 or $0.01 per basic and diluted share. This is in comparison with a Net Loss of $1.87 million or $0.19 per basic and diluted share from the same period last year.

Jean-Louis Casabonne, hopTo’s interim Chief Executive Officer, said, "The GO-Global business continues to generate positive cash flow and remains a critical aspect of the company. The GO-Global business has now shown modest growth year over year for both the three and nine month periods ended September 30, 2017 strengthening our belief that it will operate profitably in the future. Early in the third quarter, we completed a sale of seven of our fifty-three granted patents which has further improved the cash position of the Company. This sale included a license back to hopTo for those patents."

hopTo, Inc. (HPTO), closed Friday's trading session at $0.20, even for the day, on 42,266 volume with 9 trades. The average volume for the last 3 months is 4,776 and the stock's 52-week low/high is $0.099/$0.46.

chart

Consumer Capital Group, Inc. (CCGN)

Stock Twits, Stockhouse, Wallet Investor, OTC Markets, Morningstar, Street Insider, Market Exclusive, 4-Traders, Stockopedia, and last10k reported previously on Consumer Capital Group, Inc. (CCGN), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Consumer Capital Group, Inc.’s plan is to become a foremost Financial Technology (FinTech) company, which focuses on comprehensive financial advisory services for micro, small-to-medium sized enterprises (SMEs) in China. The Company, by way of its subsidiaries, provides microfinancing and financial advisory services to micro, and SMEs. Additionally, it provides financial consulting services. Incorporated in 2008, Consumer Capital Group is headquartered in Flushing, New York.

The Company mainly engages in two core businesses. These are microfinancing and financial advisory service.Consumer Capital Group provides advisory and risk assessment services to lenders and borrowers to help boost the efficiency of loan origination by financial institutions. The Company provides direct loans to SMEs and sole proprietors. It also provides private loans to borrowers. Consumer Capital Group also acts as an intermediary to facilitate the loan transactions.

Consumer Capital Group offers financial consulting services. These services include loan origination criteria checkup, risk assessment, and loan monitoring services on a third-party peer to peer online lending platform to SMEs and financial institutions.

In addition, the Company offers wealth management services through a financial advisory platform. This platform attracts capital from investors to invest in fixed income opportunities, including inter-bank loans, currency exchange products, and other equity investment opportunities to realize return on their investments (ROI).

Furthermore, Consumer Capital Group offers asset management, management consulting, as well as Internet information services. It additionally offers advertising design, production, agent, and publishing services.

The Company operates its direct micro-financing business via its subsidiary, Arki E-Commerce, and its VIE, Arki Network. It operates its financial advisory service through Arki Network’s wholly-owned subsidiary Yin Hang.

Yin Hang (acquired by Arki Network in December 2016) commenced its operations in 2013. Yin Hang has developed its own big data risk assessment system to provide credit rating and risk management solutions to borrowers and financial institutions.

Through Arki Network’s collaboration with China UnionPay Merchant Service (Liaoning) Co. Ltd (UnionPay Liaoning), Arki E-Commerce provides private loans for borrowers and Arki Network and UnionPay act as intermediaries to make possible the loan transactions for a 2 percent service fee.

Consumer Capital Group, Inc. (CCGN), closed Friday's trading session at $3.50, up 16.67%, on 500 volume with 2 trades. The average volume for the last 3 months is 1,346 and the stock's 52-week low/high is $1.009/$8.80.

chart

Integrity Applications, Inc. (IGAP)

OTC Markets Group and SmallCapVoice reported previously on Integrity Applications, Inc. (IGAP), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Integrity Applications, Inc. is the maker of GlucoTrack®. This is a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes. GlucoTrack® is a monitoring device that quickly measures and displays an individual's glucose level in about a minute without finger pricking or any pain. GlucoTrack® has received CE Mark and KFDA approvals for type 2 diabetes and pre-diabetes. It is now in the early stages of commercialization in Europe, South Korea, as well as other geographies.

Formed in 2001, Integrity Applications is a Delaware corporation with its head office in Wilmington, Delaware and a research and development (R&D) site in Ashdod, Israel. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Integrity Applications is concentrating on three important initiatives - GlucoTrack Commercialization in Europe; GlucoTrack U.S. FDA (Food and Drug Administration) Approval; and a Product Roadmap. The Company’s initial main emphasis is on the commercialization of GlucoTrack in Europe.

Regarding U.S. FDA Approval, Integrity Applications has been working with regulatory and clinical experts to clarify the best regulatory pathway for the GlucoTrack. Based on feedback from the FDA, the Company plans to follow a de novo 510k pathway. It expects to begin the U.S. study in early to mid-2018, subject to funding and consultation with the Agency.

Concerning the Product Roadmap, Integrity’s intention is to apply its proprietary technology platform to leverage new developments and trends in the marketplace.

GlucoTrack® features a small sensor. This sensor clips to the earlobe and measures the user's glucose level utilizing innovative and patented sensor technology. The measured signals undergo analysis employing a proprietary algorithm and then a calculated glucose level is displayed on a small handheld device the size of a small mobile phone.

The glucose results are stored in the device and used to project an estimated HbA1c level utilizing a proprietary algorithm. Furthermore, the device can display glucose values graphically, enabling the user to monitor glucose levels over time. GlucoTrack® is currently experimental in the United States. It is limited to investigational use only.

In late December 2017, Integrity Applications announced that it entered into an exclusive distribution agreement with MediReva B.V. for the GlucoTrack® in the Netherlands. MediReva is a family owned business. It comprises a group of companies centered on home healthcare and the distribution of specialty medical products with wide-ranging experience with blood glucose monitoring and diabetes care. The agreement became effective on December 22, 2017.

The Netherlands represents a vital first market for the creation of a scalable blueprint to be used in other European markets where there are about 58 million people living with diabetes. This represents roughly 8.8 percent of the adult population.

Integrity Applications, Inc. (IGAP), closed Friday's trading session at $0.20, up 17.65%, on 2,500 volume with 1 trade. The average volume for the last 3 months is 1,906 and the stock's 52-week low/high is $0.17/$4.11.

chart

Giga-tronics Incorporated (GIGA)

StockTwits, InvestorsHub, Stockhouse, Stock News Gazette, and SmarterAnalyst reported on Giga-tronics Incorporated (GIGA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Giga-tronics Incorporated produces instruments, subsystems, as well as sophisticated microwave components. These have wide-ranging applications in defense electronics, aeronautics, and wireless telecommunications. Listed on the OTCQB, the Company operates in the Scientific & Technical Instruments industry in the Technology sector. Giga-tronics has its corporate headquarters in Dublin, California.

Giga-tronics works to help solve the world’s next generation Radar and Electronic Warfare problems. It accomplishes this with state-of-the-art high speed signal generators, sub-system and sub-assembly, test and measurement equipment. Giga-tronics product lines include Advanced Signal Generation and Analysis test equipment. It also includes Microsource sub-system and sub-assembly TBRF technology products.

The Company’s Advanced Signal Generator and Analysis System is a family of Real-Time Synthesizers (RTS). The design of these is as modular building blocks for agile signal generation and downconversion of signals with up to 1 GHz of instantaneous bandwidth.

Regarding the Real-Time Threat Emulation System for Electronic Warfare, Giga-tronics’ Threat Emulation Systems (TEmS) permit engineers to imitate real-world environments from bench, chamber, and hangar environments to help identify and fix design issues well before mission day.

Furthermore, the Giga-tronics Multi-Platform Threat Emulation System is a fully integrated combination of multiple COTS configurable systems, sub-systems, software, and numerous kinds of COTS AWGs. These can stream a RF/Microwave scenario, which represents real world threat and target emitters in a complex environment.

Recently, Giga-tronics announced that it received an additional $4.9 million order. This extends continuing production of the Company’s high performance RADAR filters for a major aerospace company. Giga-tronics expects to commence initial shipments of the new order during Q4 of Fiscal 2018. It also expects to complete the bulk of the new order shipments over the succeeding 9 to 12 month period.

Earlier this month, Giga-tronics reported Net Sales for Q2 of Fiscal 2018 of $2.2 million. This represents a 49 percent decrease versus $4.4 million for Q2 of Fiscal 2017. Net Sales for the six-month period ended September 30, 2017 were $4.2 million. This represents a decrease of 46 percent, versus $7.8 million for the six-month period ended September 24, 2016.

This drop in Net Sales for both periods were chiefly because of lower sales associated with the legacy products (sold to Astronics in June of 2016); a drop associated with the Company’s new ASG product; a decrease mainly associated with the winding down of non-recurring engineering services and lower product revenues following the completion of the $4.5 million order for YIG RADAR filters in Q1 of Fiscal 2018.

Giga-tronics Incorporated (GIGA), closed Friday's trading session at $0.32, up 14.29%, on 4,000 volume with 3 trades. The average volume for the last 3 months is 15,350 and the stock's 52-week low/high is $0.17/$0.589.

chart

Integrated BioPharma, Inc. (INBP)

StockMister, OTCPicks, HotShotStocks, Wall Street Mover, Zacks, The Stock Psycho, Top Gun, and AllPennyStocks reported earlier on Integrated BioPharma, Inc. (INBP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Integrated BioPharma, Inc. engages primarily in the manufacture, distribution, marketing, and sales of vitamins, nutritional supplements, and herbal products. Its customers are mainly in the United States, Luxembourg, and Canada. Integrated BioPharma develops, manufactures, and distributes, around the world, in excess of 130 products. The Company does so through several wholly-owned subsidiaries.

Integrated BioPharma formerly went by the name Integrated Health Technologies, Inc. Established in 1979, the Company is based in Hillside, New Jersey. Integrated BioPharma lists on the OTC Markets.

Integrated Biopharma’s companies include AgroLabs, Inc., Chem International, IHT Health Products, Inc., Manhattan Drug Company, and Vitamin Factory. Integrated BioPharma operates via three segments. These are Contract Manufacturing, Branded Proprietary Products, and Other Nutraceutical Businesses.

AgroLabs manufactures and markets healthful nutritional products under the Naturally Noni, Naturally Pomegranate, Naturally Aloe, and Naturally Mangosteen brands. Additionally, AgroLabs distributes internationally, in Canada, Germany, Japan, Korea, Mexico, Taiwan and the United Kingdom (UK). Integrated BioPharma’s Chem International offers a broad assortment of Roche Vitamins' food and cosmetic products.

The Company’s Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. Its Branded Proprietary Products segment distributes healthful nutritional products for sale through mass market, grocery, drug, as well as vitamin retailers.

The Other Nutraceutical Businesses segment sells private label vitamin and nutritional supplement products, and healthful nutritional products through the Internet. In addition, this segment distributes fine natural botanicals. This includes multi minerals and raw materials. Moreover, the Other Nutraceutical Businesses segment provides warehousing and fulfilment services.

Integrated BioPharma’s Vitamin Factory sells nutritional supplements directly to the consumer by way of mail order catalogs and over the Internet. Vitamin Factory’s product categories are dietary supplements, liquid items, sports supplements, and skincare supplements.

Manhattan Drug Company provides vitamins and nutritional formulations. It engages in the manufacturing of tablets, capsules, or blends; packaging and labeling in bulk; help in product registration worldwide, and distribution of finished product. Also, Manhattan Drug Company engages in analytical and microbiological testing via its in-house laboratories.

Integrated Biopharma’s IHT Health Products sells and distributes fine chemicals. These include science-based proprietary products and value added formulations. IHT sells and distributes these to the nutritional, pharmaceutical, food, and cosmetic industries. IHT products include vitamins, amino acids, herbal extracts, Over-the-Counter (OTC) pharmaceuticals, excipients, and unique patented products.

Integrated BioPharma, Inc. (INBP), closed Friday's trading session at $0.1299, up 28.61%, on 1,400 volume with 2 trades. The average volume for the last 3 months is 6,353 and the stock's 52-week low/high is $0.1009/$0.20.

chart

Torex Gold Resources, Inc. (TORXF)

Hotstocked, Marketbeat, Mining Stock Valuator, Tip Ranks, Dividend Investor, Northern Miner, InvestorsHub, Resource World, Emerging Growth, Barchart, 4-Traders, Northern Vertex, The Assay, Penny Stock Tweets, World Trading Data, Stockhouse, Capital Cube, YCharts, Midas Letter, Wallet Investor, and Market Screener reported on Torex Gold Resources, Inc. (TORXF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Torex Gold Resources, Inc. engages in the exploration, development, and operation of mineral properties. The Company explores for gold, silver, and copper deposits. An intermediate gold producer, it engages in the exploration, development and operation of its 100 percent owned Morelos Gold Property. This is an area of 29,000 hectares in the highly prospective Guerrero Gold Belt situated 180 kilometers southwest of Mexico City. Torex Gold Resources is headquartered in Toronto, Ontario.

The Company’s principal assets include the El Limón Guajes Mining Complex, comprising the El Limón, Guajes and El Limón Sur open pits, the El Limón Guajes underground mine including zones referred to as Sub-Sill, El Limón Deep, and the processing plant and related infrastructure, which commenced commercial production in April of 2016.

Additionally, Torex’s principal assets include the Media Luna Deposit, an early stage development project, and for which the Company issued a Preliminary Economic Assessment (PEA) in 2015. This property remains 75 percent unexplored.

El Limon-Guajes is Torex’s first Mine. The El Limon-Guajes Mine (ELG), positioned north of the Balsas River, constitutes one of the richest open pit gold deposits at a resource grade of 2.65 g/t. The Mine began gold production in December of 2015. On March 30, 2016, it announced commercial production. Upon being in full production, the Mine will be among the largest and lowest cost gold mines worldwide with expected LOM average annual production of 370,000 ounces of gold at a LOM AISC (All in Sustaining Cost) of US$616/oz.

The Media Luna deposit is hosted in a magnetic anomaly south of the Balsas River. It was discovered in March 2012. It has current Inferred Resources of 7.4 million gold equivalent ounces at a grade of 4.48 g/t.

The resource is contained in less than 30 percent of the area of the targeted magnetic anomalies. The conceptual design contained in a positive PEA (Preliminary Economic Assessment) announced in July of 2015 anticipates an underground operation with expected average annual production of 313,000 ounces of gold equivalent at an average AISC of US$636/oz.

Last month, Torex Gold Resources announced the results from 57 holes, from its in-fill and step-out drilling programs in the Sub-Sill Zone of its El Limón Guajes (ELG) Underground Mine in Southwest Mexico. Highlighted intercepts from this program include 30.2g/t Au over 8.1 m in borehole SST-101; 48.9g/t Au over 3.6 m in borehole SST-118; and 34.4g/t Au over 4.6m in borehole SSUG-059. The deposit remains open in a number of directions. The 57 holes reported represent all Sub-Sill results received up to September 5, 2018.

Torex Gold Resources, Inc. (TORXF), closed Friday's trading session at $8.95, up 7.90%, on 3,928 volume with 16 trades. The average volume for the last 3 months is 13,438 and the stock's 52-week low/high is $5.728/$11.80.

chart

Wildflower Brands, Inc. (WLDFF)

StocksNewsFeed, Stockhouse, InvestorPlace, Morningstar, Dividend Investor, Investors Hangout, Barchart, The Hot Penny Stocks, Jet Life Penny Stocks, Stockwatch, Micro Small Cap, Emerging Growth, Penny Stock Hub, MarketWatch, Wallmine, GuruFocus, Market Screener, Midas Letter, InvestorsHub, TradingView, and The Street reported earlier on Wildflower Brands, Inc. (WLDFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Wildflower Brands, Inc. is centering on building reputable brands and quality products that incorporate the synergistic effects of plants and their extracts. The Company formerly went by the name Wildflower Marijuana, Inc. It changed its corporate name to Wildflower Brands, Inc. in April 2018. OTCQB-listed, Wildflower Brands is based in Vancouver, British Columbia.

Wildflower’s mission is to connect people with the healing power of plants. The Company develops its products through listening to the mature cannabis-smart consumers and experienced dispensary bud tenders’ feedback. Wildflower works to find the best technologies, use the highest quality cannabis, and pair it with the most synergistic ingredients to maximize the benefits of cannabis.

The Company offers a complete line-up of wellness focused cannabis infused products. All of its products are made in America by Wildflower in its GMP certified facilities and third-party lab tested for quality assurance and accurate labeling.

The Company has its Wildflower by Bridges General branded stores. Wildflower by Bridges General branded stores will feature the Company’s existing online catalog of products. In addition, they will feature in-store only exclusive products designed specifically for the New York market.  Bridges General is a unique retail concept by Wildflower’s partner Retail Worx. The first three locations include 11 Times Square; 770 Broadway; and 11 Madison Avenue.

Recently, Wildflower Brands announced that it received a Memorandum of Understanding (MOU) with one of the top cannabis delivery technology companies in the State of California. The MOU is the initial step for Wildflower to activate delivery from the California licenses, which were acquired earlier in 2018. Wildflower’s intention is to serve the western part of the Los Angeles area.

Last week, Wildflower Brands announced greater than $1M in sales in its first quarter, versus $103,893 in Q1 of the prior year. Sales from all sources are up from the prior quarter. The largest increase came from sales to health and wellness retailers across the U.S.  This marks the 9th consecutive quarter of increased revenue.

Wildflower Brands, Inc. (WLDFF), closed Friday's trading session at $0.4527, up 13.66%, on 37,443 volume with 25 trades. The average volume for the last 3 months is 42,036 and the stock's 52-week low/high is $0.009/$1.139.

chart

Bitcoin Investment Trust (GBTC)

Investopedia, Morningstar, MarketWatch, SlashGear, Stockhouse, Finance Registrar, Stock Twits, Zacks, CryptoCurrencyFacts, Stock Investor, Cointelegraph, Street Insider, Strategic Coin, TradingView, Bitcointalk, The Street, Business Insider, Investor Place, MintDice, Wallet Investor, and Brave New Coin reported earlier on Bitcoin Investment Trust (GBTC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Grayscale Investments, LLC is an authority on digital currency investing. The Company provides secure access to the digital currency asset class through its single-asset and diversified investment products. These include Bitcoin Investment Trust™ (GBTC) and Digital Large Cap Fund™.

Established in 2013 by Digital Currency Group, Grayscale Investments has its corporate office in New York, New York. The Company’s shares trade on the OTC Markets Group’s OTCQX.

Bitcoin Investment Trust™ is a privately offered trust and available exclusively to accredited investors. Bitcoin Investment Trust’s investment objective is for the value of its shares to reflect the price performance of bitcoin, minus fees and expenses. Bitcoin Investment Trust was created for investors looking for exposure to bitcoin by way of a traditional investment vehicle.

Bitcoin Cash Investment Trust™ is a privately offered trust and is available exclusively to accredited investors. Bitcoin Cash Investment Trust’s investment aim is for the value of its shares to reflect the price performance of Bitcoin Cash (BCH), minus fees and expenses. Bitcoin Cash Investment Trust was created for investors looking for exposure to BCH via a traditional investment vehicle.

Grayscale Investments has launched Zen Investment Trust. This is a single-asset investment vehicle solely consisting of ZEN, a privacy-focused digital currency. Zen Investment Trust is the eighth single-asset investment product introduced by Grayscale Investments. It is also the first security solely invested in ZEN. ZEN is a privacy-oriented digital currency. It is native to Horizen (formerly ZenCash), a decentralized technology platform, which provides users with complete control of their digital footprint.

In addition to its single-asset products, Grayscale Investments also manages the aforementioned Digital Large Cap Fund™. This is a diversified investment product that provides exposure to the top digital currencies by market capitalization.

Grayscale sponsors single-asset investment products that provide exposure to Bitcoin (BTC), Bitcoin Cash (BCH), Ethereum (ETH), Ethereum Classic (ETC), Litecoin (LTC), XRP, Zcash (ZEC), and ZEN. In the first six months of 2018, Grayscale raised close to $250 million across its suite of investment products.

Bitcoin Investment Trust (GBTC), closed Friday's trading session at $3.98, down 7.23%, on 5,126,608 volume with 5,344 trades. The average volume for the last 3 months is 1,682,714 and the stock's 52-week low/high is $4.26/$38.71.

chart

The QualityStocks Company Corner

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently leveraged the trademarked ability of its DehydraTECH technology to deliver cannabinoids by entering a new partnership with Cultivating Wellness Inc. (“CW”) to formulate the ChrgD+ premium brand. To view the full article, visit: http://nnw.fm/uKb6O.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.18, up 25.53%, on 518,144 volume with 266 trades. The average volume for the last 3 months is 221,438 and the stock's 52-week low/high is $0.775/$2.54.

Recent News

chart

American Premium Water Corp. (HIPH)

The QualityStocks Daily Newsletter would like to spotlight American Premium Water Corp. (HIPH).

American Premium Water Corp. (HIPH) was highlighted today in a Cannagreed.com News Commentary report, explaining that, while stocks have taken a beating due to trade concerns with China and rising rates, there is green at the end of the tunnel! With the expected vote and passage of the 2018 Farm Bill on Monday, stocks that are in the CBD space are poised to benefit and should run counter to the current market downward trends.

American Premium Water Corp. (HIPH), headquartered in Playa Vista, California, is a diversified holding company, manufacturer, distributor and marketer of branded consumer products. HIPH, the acronym for “Hi-Power of Hydro,” maintains a portfolio of subsidiaries catering to the health-conscious consumer and luxury fashion brand connoisseur. The company’s two main pillars focus on the development of health and beauty biotech, dedicated to unlocking the power of hydrogen and nanotechnologies. Paired with cannabidiol or “CBD” in a unique beverage, the technology is proving to be a significant health and wellness option for astute consumers.

Among the company’s holdings are:

  • LALPINA Hydro beverages mix hydrogen with nanotechnology into consumer beverages that combine the best of health, nutrition and fitness to deliver short and long-term therapeutic health benefits. LALPINA Hydro utilizes atomic molecular hydrogen, or diatomic hydrogen, which converts antioxidants in the body to H2O to further enhance hydration, which helps increase endurance, reduce lactic acid and melt away fatigue. Over 500 peer-reviewed articles demonstrate hydrogen to have therapeutic potential in essentially every organ of the human body and in 150 different human disease models.
  • LALPINA Hydro CBD is a technically superior CBD-infused beverage. Using hydro and nanotechnology, LALPINA Hydro CBD encapsulates water molecules with cannabidiol molecules, making them infinitely more bioavailable and accelerating delivery to the body’s cells and tissues. Each bottle of LALPINA Hydro CBD contains 3 million nanograms of CBD free from the psychoactive compound THC (tetrahydrocannabinol). HIPH is the first to introduce a hydro-nano CBD-infused beverage on the market, which is a more effective delivery mechanism for administering CBD into the blood stream than traditional beverages or oils, with up to a 90 percent higher absorption rates.

The company recently signed a distribution agreement for its subsidiary, LALPINA Hydro CBD, to sell its beverages to two SinglePoint, Inc. (OTCQB: SING) e-commerce channels: SingleSeed.com and DIGSHydro.com. SING is a technology and investment company with a portfolio that includes mobile payments, blockchain solutions and ancillary cannabis services. HIPH will drop ship its product to the customers.

HIPH CEO Ryan Fishoff said the e-commerce arrangements “could bring in excess of a million of revenue over the life of the agreement.” The agreement serves as a pillar of the company’s e-commerce distribution strategy, driving awareness and impressions for the LALPINA brand.

In addition, HIPH seeks to market emerging fashion brands and leverage its relationship with classic retail partners while incorporating disruptive blockchain technologies to expand its retail footprint with the following:

  • Gents, a producer of luxury hats and other fine accessories and apparel, was acquired in September 2017. Gents is distributed across many luxury retail outlets including Saks Fifth Avenue, Bloomingdales, Nordstrom, and other high-end channels. The company added the Worthy streetwear brand to its portfolio in June 2018.
  • HIPH also acquired the license to operate the FashionCoinX exchange, a blockchain exchange focused on creating utility tokens for the fashion industry, and created THRD Coin, a multi-branded utility rewards token that is also the first token to be traded on the exchange. The company is leveraging its retail footprint and expertise in the fashion and apparel space with the burgeoning blockchain sector.

American Premium Water Corp. (HIPH), closed the day's trading session at $0.0351, up 59.55%, on 32,944,133 volume with 1,050 trades. The average volume for the last 3 months is 19,557,052 and the stock's 52-week low/high is $0.0035/$0.1319.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) was highlighted today in a report by CannabisNewsWire, which examines how the seemingly endless supply shortages ever since recreational cannabis was legalized have started having a domino effect within the Canadian pot industry. The latest news is that the province of Alberta will not issue any more cannabis retail licenses for up to 18 months, unless the supply shortages are addressed by the licensed producers who are mandated to grow and avail cannabis to the recreational and medical cannabis markets.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.11, up 5.71%, on 334,181 volume with 344 trades. The average volume for the last 3 months is 803,523 and the stock's 52-week low/high is $0.939/$2.79.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (US:TGODF) is pleased to announce the voting results from its annual general and special meeting of shareholders of the Company ("Shareholders"), held in Mississauga, Ontario on December 6, 2018 (the "Meeting").

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.3706, up 12.91%, on 925,498 volume with 1,208 trades. The average volume for the last 3 months is 1,493,588 and the stock's 52-week low/high is $1.87/$7.89.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

CannabisNewsAudio announces the Audio Press Release (APR) titled “Hemp Industry Sees Profitable Harvest as Farm Bill Approaches Finale,” featuring Sugarmade, Inc. (OTCQB: SGMD). To hear the CannabisNewsAudio version, visit: http://cnw.fm/S2jfk. To read the full editorial, visit: http://cnw.fm/f5fdN. Also today, CannabisNewsWire released a report on the company detailing SGMD’s expected revenue growth in hydroponic related supplies amidst the rapidly-changing California cannabis cultivation licensing environment.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.1063, up 9.03%, on 1,714,279 volume with 176 trades. The average volume for the last 3 months is 2,226,761 and the stock's 52-week low/high is $0.0619/$0.43.

Recent News

chart

Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Golden Developing Solutions, Inc. (OTC: DVLP) is emerging as a cannabis industry leader, offering to dispensaries multiple suggestions for success prior to introducing its Greener Grows software division. The company’s Greener Grows division is designed to offer industrywide data on cannabis growing and, at the same time, increase awareness of DVLP (http://nnw.fm/lv7Ms). Also today, NetworkNewsWire released a report on the company, digging deeper into the launch of the company’s new software division.

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.

WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.018675, up 8.89%, on 130,885 volume with 16 trades. The average volume for the last 3 months is 754,025 and the stock's 52-week low/high is $0.0125/$0.14.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally-syndicated program reviews money-focused topics and features in-depth interviews with CEOs and executives from various companies offering insights into their operations and future outlooks. To view the full press release, visit: http://nnw.fm/uH69h.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0171, up 3.61%, on 3,567,427 volume with 150 trades. The average volume for the last 3 months is 4,537,958 and the stock's 52-week low/high is $0.014/$0.1189.

Recent News

chart

Victory Marine Holdings Corp. (VMHG)

The QualityStocks Daily Newsletter would like to spotlight Victory Marine Holdings Corp. (VMHG).

As the recreational boating market is seeing healthy growth, Miami-based Victory Marine Holdings (OTC: VMHG) has purposefully secured a strong position within the sector. To view the full article, visit: http://nnw.fm/Vs8Id.

Victory Marine Holdings Corp. (VMHG) is a world-class yacht sales, brokerage and consulting firm with a sprawling inventory of new and used boats, financing, insurance, documentation and recreational marine accessories. Located in Miami, Florida – the “yacht capital of the world” – Victory Marine has over 20 years of experience in an industry hailed as “an American pastime and economic engine” by the National Marine Manufacturers Association (“NMMA”).

According to the NMMA, marine sales reached $39 billion in 2017. To capture its share of this market, Victory Marine has established partnerships with several selective manufacturers and is pursuing opportunities for vertical growth. While the company’s near-term focus is on expansion of its inventory and sales team, its longer-term plans reflect the current state of the broader yacht industry.

Marine sales are at a 10-year high, and though yacht manufacturers are operating at full capacity, delivery of some products can take longer than 18 months. As a result, Victory Marine is taking steps to establish its own pipeline. Management is currently in negotiations with several yacht manufacturers to build the company its own unique, private-label design, which would enable Victory Marine to quickly deliver a superior product to its clients.

Demand for recreational boat trailers is also on the rise, with growth reported for nearly all powerboat segments. Florida continues to ride the top of that crest with sales of powerboats, trailers, and accessories up 10 percent in 2017 to $2.9 billion, followed by Texas ($1.7 billion) and Michigan ($982 million).

Victory Marine’s wholly owned Excalibur Trailers USA subsidiary is set to take advantage of this market, and is approved by the Society of Automotive Engineers (SAE International) to build custom marine aluminum trailers for recreational boats, as well as for commercial boat transport. Excalibur Trailers USA has filed the necessary paperwork to trademark its brand name and logo and is seeking a suitable manufacturing facility in South Florida for production of powerboat, sailboat, catamaran, powerboat and Jet Ski trailers.

Leading Victory Marine to capture its share of the market is company CEO Orlando Hernandez, whose experience in the marine industry includes negotiation, business planning, investor relations, operations management and sales. He is joined by veteran yacht broker Gary Beaver, who has more than 20 years of successful yacht sales and industry experience. Beaver brings to Victory Marine his portfolio of approximately 25 vessel listings, valued in excess of $10 million.

Victory Marine Holdings Corp. (VMHG), closed the day's trading session at $0.05225, up 1.95%, on 7,250 volume with 2 trades. The average volume for the last 3 months is 62,460 and the stock's 52-week low/high is $0.044/$0.97.

Recent News

chart

Pacific Software, Inc. (PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Pacific Software (OTC: PFSF) is aiming to relieve the growing tension regarding trade between Brazil and China through the development of a proprietary e-commerce trade platform that can track complex transactions using cryptographically secure Hyperledger Blockchain technology. To view the full article, visit: http://nnw.fm/zIT1W.

Pacific Software, Inc. (PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture and the opioid epidemic.

The basic requirements of the systems to be developed include high-throughput transaction processing, traceability or tracking, visibility or monitoring, and transparency throughout the supply and value chains for the stakeholders. The development of this architecture will serve as an online commercial portal to service Pacific Software’s B2B accounts in the sectors below.

Agriculture
For application of its Agri-blockchain based system, Pacific Software will target farm-to-consumer exports to increase transparency, combat theft and counterfeit products, and reduce the health risks associated with shipping “tainted” agricultural products to other countries.

Controlled Substances
With the misuse of opioids on the rise worldwide, Pacific Software aims to apply its blockchain-based system to track opioids from pharmaceutical production to consumers and attempt to identify “Bad Actors” in the supply chain and fight against the global epidemic.

Business Model
The portal will be structured in a B2B format where clients will pay the company transaction fees, royalties, cash, cash equivalents and other forms of compensation to utilize its Hyperledger blockchain applications for their business models.

As the company executes these strategies, each Hyperledger blockchain-based system designed may be organized separately in wholly owned subsidiaries. To enhance its portfolio of holdings, Pacific Software may consider investments in companies where selected markets have imminent profitable results, providing appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $5.50, even for the day. The average volume for the last 3 months is 63 and the stock's 52-week low/high is $3.50/$5.50.

Recent News

chart

Cyberfort Software, Inc. (CYBF)

The QualityStocks Daily Newsletter would like to spotlight Cyberfort Software, Inc. (OTC: CYBF).

Global losses from cyberattacks continue to generate headlines, with major hacks affecting nearly every segment of society. A “cybercrime pandemic” in 2017 may have cost the world as much as $600 billion, and analysts expect the trend to continue its upward trajectory, a CNBC article states (http://nnw.fm/qJ82N). San Francisco-based Cyberfort Software, Inc. (OTC: CYBF), a cybersecurity technology company targeting the global cybersecurity market, is committed to the idea that everyone – from individuals to global corporations – should be able to enjoy the Internet without malicious attacks on their privacy and security.

Cyberfort Software, Inc. (CYBF) is a cybersecurity technology company specializing in the acquisition and development of security software, content filtering, and ad blocking technology. Headquartered in San Francisco, California, Cyberfort Software is actively dealing with various cyber threats through the development of innovative protection technologies designed for mobile, personal and business tech devices across multiple platforms.

Committed to the idea that everyone – from individuals to global corporations – should be able to enjoy a digital future free of malicious attacks robbing them of privacy and security, Cyberfort is working to strengthen its portfolio of cybersecurity IPs and stay one step ahead of cyberthreats. The growing plethora of tech devices enveloping everyday life opens the door to increasing cyberattacks through a stunning array of sophisticated cyberthreats. Protecting organizations and individuals with proactive security postures and protective measures is a key component of Cyberfort’s strategy to develop cybersecurity solutions that are smart, simple and efficient.

The company’s 2016 purchase of Vivio, a provider of pioneering AI content filtering and software protection, underscores Cyberfort’s commitment to cybersecurity. Vivio, an iOS 10 ad blocking app, currently serves over 10,000 unique users across iPhone, iPad and Mac. Vivio makes web browsing better, faster and more satisfying by blocking ads and reducing data usage, which also helps save battery life. Continuous ad blocking rule updates are delivered via an Intellectual Property Cloud-based autonomous engine with ad blocking tracker and malware detection filters.

Cyberfort recently signed a letter of intent to acquire Just Content Software which includes the Just Content app, software and underlying source code. Just Content is an efficacious and multi-functional ad blocking app that safeguards families and businesses with proprietary “Home Safe Filter” and “Business Filter” products. The Just Content app is available on iTunes and protects against unsafe links, adult content, phishing sites and inflammatory hate speech found on the internet, among other potential backdoor attacks and cyberthreats. A due diligence review is underway and a final determination regarding this acquisition is anticipated within weeks.

“Cyberfort aims to become a leader in developing cutting edge ad-blocking protective software that keeps the internet safe for families and business, which in our highly technological and immediate information-access society is a significant concern. Acquiring Just Content furthers our commitment to provide the best and most effective ad-blocking software in the marketplace,” says Cyberfort CEO Daniel Cattlin.

Favorable government regulations promoting tightened web security is a major factor driving adoption of web content filtering solution along with the public’s growing desire to better manage network bandwidth consumption and protect their online security and privacy. Cyberfort’s objective is to protect the data and integrity of personal and business computing assets and defend those assets against any threat or attack. The company’s software also offers symbiotic ad-blocking capabilities to complement its cyber defense effectiveness.

As Cyberfort continues to innovate, the Vivio team intends to leverage the current user base as a sandbox to test and optimize future incremental developments targeting an enterprise suite of tools that can be integrated into sector specific areas of growth. Key areas of focus include mobile device management, bring your own device (“BYOD”), mobile app management and secure mobile browser.

The Cyberfort leadership team is headlined by Cattlin, who offers a new age perspective to the business with expertise in project and asset management and a background in corporate finance. Cattlin brings both the operational and financial understanding to take companies from start-up and early development to expansion and capital growth within a public environment.

Chief Technology Officer Tomas Mistrik helped his team deliver a variety of technological products including the Vivio ad-blocking app for iOS 10 and the Silicon Valley-based Synergykit platform for mobile developers.

Technology Development Manager Krishna Kumar brings more than 10 years of experience in the Information Technology industry where he provided powerful security and ad-blocking measures for companies such as CSC and PayPal India.

Senior Advisor Harish Doddala brings nine years of product management and software engineering experience, delivering results for Cisco, VMware, Oracle, IBM and Siemens.

Cyberfort Software, Inc. (OTC: CYBF), closed the day's trading session at $0.50, even for the day, on 12,548 volume with 11 trades. The average volume for the last 3 months is 16,746 and the stock's 52-week low/high is $0.051/$69.00.

Recent News

chart

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)

The QualityStocks Daily Newsletter would like to spotlight Therma Bright, Inc. (OTC: THRBF).

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) continues to develop a new pain relief device that incorporates the company’s thermal therapy technology with medical grade cannabis or cannabidiol (CBD) sourced from hemp as a cream or gel to provide relief of back, knee and other joint pain. A wholly owned subsidiary is being incorporated to hold any device or technology that Therma Bright develops for use or application of cannabis, the company announced in a news release (http://nnw.fm/u3Xr5).

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) is a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical industry. The company’s effective, non-invasive and pain-free skin care is based on proprietary technology which has received Class II medical device status from the U.S. Food and Drug Administration.

Therma Bright’s portfolio includes products, devices and treatments that have both cosmetic and medicinal or therapeutic benefits, such as for relief of pain, itch and inflammation resulting from more than 20,000 types of insect and marine life bites and stings, including bees, wasps, hornets, mosquitos, black flies and jellyfish.

The Company’s current focus is to market its products online through various social media networks, and to eventually re-establish relationships with major North American and Global retailers.

Products

The company currently has two products on the market and another in the research and development phase:

InterceptCS™ is a thermal therapy device for the treatment and prevention of cold sores caused by the herpes simplex Type 1 virus*. Symptoms typically include sores around the mouth and lips which InterceptCS™ treats by application of controlled topical heat with no risk of burning the skin. When used at the first sign of an oncoming cold sore application of InterceptCS™ can prevent symptoms from developing. Infrared energy and light from the device penetrate the skin killing cells infected with the virus.

InterceptCS™ is available without prescription and comprises a battery powered ergonomic hand-held unit and a disposable single-use treatment activator. Therma Bright has completed prototyping of multi-use activators for InterceptCS™. The company plans to bring to market 5, 10 or 20 multi-use activations at prices that will offer customers greater value than the current single-use activator.

The other Therma Bright product currently under development is TherOZap™, a next generation thermal therapy device powered by the company’s core technology, which is approved by the FDA as a Class II medical device for the relief of the symptoms of insect bites. Therma Bright is testing a new easier-to-use prototype of the device for effectiveness against Zika virus and other diseases carried by mosquitos. Once the technology proves effective, Therma Bright intends to seek regulatory approvals and extend the prototype enhancements to a new commercial version of TherOZap™.

Cannabis

Therma Bright is also conducting research and development on a unique thermal therapy device that would incorporate medical grade cannabis or cannabidiol (“CDB”) sourced from hemp as a cream or gel to provide relief of back, knee and other joint pain. In preparation, the company has incorporated a wholly owned subsidiary to hold any technology for use or application of cannabis. Once approvals are secured, the company plans to sell the device through licensed cannabis producers or retailers across Canada and in international markets where use of cannabis has been legalized. The company has initiated trademark and patent protection for its thermal therapy technology incorporating medical cannabis. Therma Bright has indicated it will seek an acquisition to help further development of this product.

Market Opportunity

A report by market intelligence firm Mordor Intelligence put the global cosmeceuticals market at a value of nearly US$47 billion in 2017 and projects it to be worth more than $80 billion by 2023, growing at a rate of almost 9.5 percent annually. Medical research estimates that somewhere between 20 percent and 40 percent of the population suffer occasional cold sore outbreaks. In Canada those figures would mean five to 10 million people, and in the U.S. some 40 million to 80 million, with recurring cold sores, representing a substantial potential market for Therma Bright.

Management

Rob Fia serves as Therma Bright chairman and CEO. Fia has extensive contacts in the investment community and the financial sector as well as knowledge of various Canadian stock exchange listing processes and requirements. His 18 years in the investment business has included equity research and advising promising early stage companies on corporate finance. Therma Bright CFO Victor Hugo is a senior financial analyst at Marrelli Support Services Inc., for which he provides CFO, accounting, regulatory compliance, and management advisory services to companies listed on the TSX, TSX Venture Exchange and other Canadian and US exchanges.

**Based on double blind placebo study, the InterceptCS™ is approved by Health Canada for the claim “For prevention of cold sores when used within 3 hours of the onset of the prodrome.” The InterceptCS™ is not approved by the United States FDA or any claim of clinical indication, clinical efficacy, and/or cure or prevention of disease.

Therma Bright, Inc. (OTC: THRBF), closed the day's trading session at $0.029, even for the day. The average volume for the last 3 months is 166 and the stock's 52-week low/high is $0.0256/$0.0289.

Recent News

chart

Sunniva, Inc. (CSE: SNN) (OTC: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Sunniva Inc. (CSE: SNN) (OTC: SNNVF) was highlighted today in a report by CannabisNewsWire examining how the seemingly endless supply shortages ever since recreational cannabis was legalized have started having a domino effect on the Canadian pot industry.

Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $2.40, off by 0.39%, on 143,357 volume with 179 trades. The average volume for the last 3 months is 101,146 and the stock's 52-week low/high is $2.33/$16.00.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (CIIX) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally-syndicated program reviews money-focused topics and features in-depth interviews with CEOs and executives from various companies offering insights into their operations and future outlooks. To view the full press release, visit: http://nnw.fm/uH69h.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.56, off by 0.88%, on 200,109 volume with 126 trades. The average volume for the last 3 months is 535,757 and the stock's 52-week low/high is $0.365/$1.58.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Innovative biotechnology company Earth Science Tech (OTCQB: ETST) today announced that its new genuine CBD/Propovit throat spray formula is nearly market-ready. ETST collaborated with Bionatus in a strategic partnership to improve the product, resulting in a new strawberry-flavored formulation enriched with ETST full-spectrum cannabinoids derived from industrial hemp. To view the full press release, visit: http://nnw.fm/c9Hfe.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.6578, off by 17.77%, on 185,530 volume with 148 trades. The average volume for the last 3 months is 119,836 and the stock's 52-week low/high is $0.421/$2.45.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.